Framingham’s BERG teams with MGH, Brigham in hunt for Alzheimer’s drug
December 13, 2017 at 07:00 AM EST
Under the partnership, BERG will scour a “biobank” of specimens from more than 2,500 people in various stages of cognitive decline in hopes of identifying key drivers of the disease.
